Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

[Hypersensitivity pneumonitis in budgerigar fanciers. A seldom recognised disease?].

Bocchia ME, Capato S, Pessina I, Spagnotto S, Vaghi A.

Recenti Prog Med. 2005 Jun;96(6):293-4. Italian.

PMID:
16078759
2.

The protective effect of transdermal broxaterol on exercise-induced bronchoconstriction.

Robuschi M, Scuri M, Spagnotto S, Gambaro G, Lodola E, Pisati R, Bianco S.

Eur J Clin Pharmacol. 1995;47(5):465-6. No abstract available.

PMID:
7720771
3.

Time-limited protective effect of inhaled frusemide against aspirin-induced bronchoconstriction in aspirin-sensitive asthmatics.

Sestini P, Pieroni MG, Refini RM, Robuschi M, Gambaro G, Spagnotto S, Vaghi A, Bianco S.

Eur Respir J. 1994 Oct;7(10):1825-9.

4.

Prevention of exercise-induced bronchoconstriction by a new leukotriene antagonist (SK&F 104353). A double-blind study versus disodium cromoglycate and placebo.

Robuschi M, Riva E, Fuccella LM, Vida E, Barnabe R, Rossi M, Gambaro G, Spagnotto S, Bianco S.

Am Rev Respir Dis. 1992 Jun;145(6):1285-8.

PMID:
1595992
5.

Bronchodilating activity of broxaterol transdermal patch and its protective effect on bronchial constriction induced by inhaled distilled water mist.

Robuschi M, Gambaro G, Spagnotto S, Scuri M, Fai V, Lodola E, Pisati R, Bianco S.

Int J Clin Pharmacol Ther Toxicol. 1991 Oct;29(10):407-11.

PMID:
1684178
6.

Inhaled frusemide is highly effective in preventing ultrasonically nebulised water bronchoconstriction.

Robuschi M, Gambaro G, Spagnotto S, Vaghi A, Bianco S.

Pulm Pharmacol. 1989;1(4):187-91.

PMID:
2520344

Supplemental Content

Loading ...
Support Center